drag according to your convenience
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
.
cambridge's bluebird bio licenses delivery tech to novartis, gsk
.
.
.